Back to top
07971459383
Send SMS    Call Me Free Send Inquiry


Cyclophosphamide Injection IP
Cyclophosphamide Injection IP

Cyclophosphamide Injection IP

Price 82.20 INR/ Vial

MOQ : 1 Vial

Cyclophosphamide Injection IP Specification

  • Life Span
  • 2 years from manufacture
  • Dosage Form
  • Injection
  • Packaging Type
  • Box
  • Indication
  • Cancer chemotherapy
  • Origin of Medicine
  • India
  • Salt Composition
  • Cyclophosphamide
  • Pacakaging (Quantity Per Box)
  • 1 vial per box
  • Brand Name
  • Nuphos
  • Drug Type
  • Allopathic
  • Ingredients
  • Cyclophosphamide
  • Physical Form
  • Injection
  • Function
  • Antineoplastic agent
  • Recommended For
  • Lymphoma, myeloma, leukemia, breast cancer, ovarian cancer
  • Dosage
  • As prescribed by physician
  • Dosage Guidelines
  • Use under medical supervision
  • Suitable For
  • Adults
  • Quantity
  • 500 mg per vial
  • Storage Instructions
  • Store below 25C
  • Reconstitution Needed
  • Yes
  • Strength
  • 500 mg
  • Color
  • White powder
  • Administration Route
  • Intravenous
  • Prescription Required
  • Yes
 

Cyclophosphamide Injection IP Trade Information

  • Minimum Order Quantity
  • 1 Vial
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 1000 Vials Per Month
  • Delivery Time
  • 7 Days
  • Main Domestic Market
  • All India
 

About Cyclophosphamide Injection IP



Capitalise on the opportunity to buy Nuphos Cyclophosphamide Injection IP, a brilliant antineoplastic agent expertly formulated for cancer chemotherapy. This resplendent white powder, reconstituted for intravenous administration, is designed for adults requiring precision cancer care. Offered at 500 mg per vial and manufactured in India, it delivers sensational efficacy against lymphoma, myeloma, leukemia, breast, and ovarian cancers. Prescription required. Each box contains one vial, guaranteeing freshness for up to two years. Store below 25C and use strictly as directed by your physician. Ideal for exporters, suppliers, and traders.

Cyclophosphamide Injection IP: Commercial Application and Cancer Therapy

Cyclophosphamide Injection IP is highly effective in the treatment of various cancers, including lymphoma, myeloma, leukemia, breast, and ovarian cancers. Majorly used in hospital and clinical settings, it functions as an antineoplastic agent targeting malignant cells. Administrated intravenously, it delivers rapid therapeutic action directly into the bloodstream. The injection is suitable strictly for adults and must be administered by a healthcare professional, ensuring patient safety and optimal outcomes in commercial and healthcare environments.


Sample Policy, Certification, and Delivery of Cyclophosphamide Injection IP

Sample requests for Cyclophosphamide Injection IP are accommodated with transparent policies-please inquire for the current asking price. Each batch is subject to stringent certification standards and regulatory compliance, guaranteeing product reliability. Swift drop-off and delivery are integral to our supply chain, with flexible timelines as per buyer requirements and location. Our distribution model is structured to facilitate smooth exporter, supplier, and trader transactions nationwide, ensuring your stock is replenished as per demand.


FAQ's of Cyclophosphamide Injection IP:


Q: How is Cyclophosphamide Injection IP administered?

A: Cyclophosphamide Injection IP is reconstituted from its white powder form and administered intravenously by healthcare professionals under strict medical supervision.

Q: What types of cancers is this injection recommended for?

A: This injection is recommended for the treatment of lymphoma, myeloma, leukemia, breast cancer, and ovarian cancer, as prescribed by a qualified physician.

Q: Where should Cyclophosphamide Injection IP be stored before use?

A: The product should be stored below 25C to maintain stability and efficacy until its expiration, which is two years from the manufacturing date.

Q: What is the process for obtaining sample vials for commercial purposes?

A: Sample requests can be made by contacting the supplier directly to discuss the asking price and terms. All samples adhere to the established sample policy and certifications.

Q: When can I expect delivery after placing an order?

A: Delivery times vary based on location and quantity, but prompt drop-off and efficient logistics are provided to meet your commercial needs.

Q: What are the primary benefits of using Cyclophosphamide Injection IP in cancer therapy?

A: The primary benefit lies in its proven effectiveness as an antineoplastic agent, enabling targeted chemotherapy for a range of malignancies when used under professional oversight.

More Products in Pharmaceutical Injection Category

Doxorubicin Hydrochloride Injection I.P. 50 Mg

Doxorubicin Hydrochloride Injection I.P. 50 Mg

Price 175 INR / Vial

Minimum Order Quantity : 100 Vials

Packaging Type : Box

Function : Other, Anticancer (chemotherapy)

Ingredients : Doxorubicin Hydrochloride

Dosage Form : Injection

Bendamustine Hydrochloride For Injection IP

Bendamustine Hydrochloride For Injection IP

Price 800 INR / Vial

Minimum Order Quantity : 1 Vial

Packaging Type : Box

Function : Other, Anticancer medication

Ingredients : Bendamustine Hydrochloride

Dosage Form : Lyophilized powder for injection

Shingrix Vaccine

Shingrix Vaccine

Price 8800 INR / Pack

Minimum Order Quantity : 10 Packs

Packaging Type : Vial and prefilled syringe

Function : Other, Prevention of herpes zoster (shingles)

Ingredients : Recombinant Varicella Zoster Virus Protein E Antigen, AS01B Adjuvant System

Dosage Form : Injection

Paclitaxel Injection I.P. 30 Mg

Paclitaxel Injection I.P. 30 Mg

Price 200 INR / Unit

Minimum Order Quantity : 1 Unit

Packaging Type : Box

Function : Other, Antineoplastic agent

Ingredients : Paclitaxel

Dosage Form : Injection